AVI BIOPHARMA, INC. - COMMON STOCK

Company

Sarepta Therapeutics, Inc.

Filed

December 15, 2003

Accession Number

0001141111-03-000016

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →